The event to discover, collaborate, and invest in the success of UK & Nordic life sciences.

The Annual Anglonordic Life Science Conference is back for 2025. Join us on the 3rd April for the 21st edition of this must-attend conference. You will have opportunities to:

• Meet decision makers at leading and upcoming drug discovery and technology companies from the UK and Nordic regions, and investment firms throughout Europe.
• Learn from major investment firms about the current status of European investment in life science technologies.
• Gain insights from experienced life science operators within the Anglo-Nordic space.

The conference features several panels, pitching sessions, 1:1 partnering, and exhibition area. Attendees will represent the following key drivers of the European life sciences growth sector:

• CEOs, CSOs and Heads of Business Development from Emerging Life Science Companies in the Anglo-Nordic sphere and Continental Europe
• Decision-makers from Europe’s key Investor firms and Pharma companies
• Key Supporters of the Life Science Ecosystem in Europe

Pricing

• R&D delegate: £600 + VAT
• Business support: £750 + VAT
• Pitch Presentation: £850 + VAT (includes 1 delegate pass)
• Investment firms with funds participate free of charge (brokers and advisors may attend at the R&D delegate rate).

MediWales members are able to benefit from a 10% discount on delegate rates using the code MDW10.

To learn more about the Anglonordic Conference, click here.